Antonio Sa Cunha
Antonio Sa Cunha is an expert in Surgery at Assistance Publique - Hôpitaux de Paris (France). Antonio Sa Cunha has authored 178 publications, the most recent in 2024, and is an investigator in 6 clinical trials, 4 of them ongoing. SLR score: 412 (community average: 125). How the SLR is computed.
LeadR Profile
Surgery
Subspecialties: Transplantation - Gastroenterology - Endocrinology
Main Topics
Publications and Clinical Studies
Profile data updated on
Expert Rankings
Top experts on the MeSH terms this expert works on
Organizations
Career arc: 2002 - 2026
Number : 178
Citations
Main journals
Best Journals
Breakdown by type
Click a legend label to hide or show it in the chart.
Latest Publications
5 most recent indexed articles
Source: Pubmed
Clinical Studies 6
Synthesis
By phase:
By status:
By type:
By Monocentric/Multicentric:
Main Topics
Cohort/Consortium Investigators 1
Ongoing Clinical Trials
4 ongoing trials started since 2021, where this expert is an investigator
Source: ClinicalTrials
| Study | Phase | Status | Start |
|---|---|---|---|
| metastatic colorectal cancer 2023-504831-42-00 — neoplasms, drug therapy, liver, neoplasm metastasis, therapeutics, colorectal neoplasms, chemotherapy | Phase 3 | Recruiting | 2025 |
| Superior Mesenteric Artery First Versus Standard Approach in Pancreaticoduodenectomy NCT07547033 — surgical oncology, pancreaticoduodenectomy, neoplasms, adenocarcinoma, mesenteric artery, superior, arteries, pancreas, mesenteric arteries, gestures, dissection, surgeons, head | N/A | Not yet recruiting | 2026 |
| Risk adapted adjuvant chemotherapy guided by the tumour stage for operated pancreatic adenocarcinoma following neoadjuvant chemotherapy with FOLFIRINOX FRENCH26 PRODIGE93 PANACHE02 Trial 2024-519048-33-00 — adenocarcinoma, drug therapy, chemotherapy, adjuvant, therapeutics, chemotherapy | Phase 2/Phase 3 | Recruiting | 2025 |
| Postoperative Anti infective Strategy Following Pancreaticoduodenectomy in Patients With Preoperative Biliary Stent NCT06123169 — stents, piperacillin, tazobactam drug combination, antibiotic prophylaxis, pharmaceutical preparations, pancreaticoduodenectomy, drug combinations, piperacillin, tazobactam, therapeutics | Phase 3 | Not yet recruiting | 2026 |
LeadR Networks
Main global connection map